Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Hepato-Gastroenterology|August 12, 2011
Localized fluid collection after carrier-bound fibrin sealant application on liver: complication or proof of efficacy? A long-term clinical observational studyIsidoro Di Carlo, Elia Pulvirenti, Adriana Toro, et al.
Seminars in Oncology|August 1, 2012
Hepatocellualar carcinoma serum markersGaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|January 29, 2016
Giant cavernous liver hemangiomas: is it the time to change the size categories?Isidoro Di Carlo, Renol Koshy, Saif Al Mudares, et al.
Case Reports in Surgery|March 25, 2015
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinomaAdriana Toro, Gaetano Bertino, Maria Concetta Arcerito, et al.
World Journal of Surgical Oncology|May 8, 2012
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literatureIsidoro Di Carlo, Maurizio Mannino, Adriana Toro, et al.
European Journal of Internal Medicine|August 16, 2012
Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: a peripheral quantitative computed tomography (pQCT) studyAgostino Gaudio, Piera Pennisi, Francesco Muratore, et al.
BMC Surgery|July 5, 2014
Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective studyAdriana Toro, Annalisa Ardiri, Maurizio Mannino, et al.
Annals of Saudi Medicine|August 3, 2011
Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitisCosimo Marcello Bruno, Maria Valenti, Gaetano Bertino, et al.
Annals of Hepatology|June 14, 2014
What is changing in indications and treatment of hepatic hemangiomas. A reviewAdriana Toro, Ahmed-Emad Mahfouz, Annalisa Ardiri, et al.
Future Oncology (London, England)|October 11, 2013
Systemic therapies in hepatocellular carcinoma: present and futureGaetano Bertino, Isidoro Di Carlo, Annalisa Ardiri, et al.
Pageof 2